The Supreme Court in the Minerva Surgical, Inc. v. Hologic, Inc. case reaffirmed that assignor estoppel is a doctrine that is alive in patent law, but also helped define and cement the boundaries of the doctrine with limits in:
blanket assignments;
unfavorable changes in law; and
post assignment developments.
Read about how the Supreme Court defined three limitations to assignor estoppel in patent cases.

